USD10
IMDX acciones
Acerca de Insight MolecularInsight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.
USD10
IMDX acciones
Acerca de Insight MolecularInsight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.
Estadísticas
VENTANA DE OPERACIÓN
Abierta
CIERRA A LAS
20:00 GMT+0
CAPITALIZACIÓN DE MERCADO
120,76 M US$
PRECIO DE APERTURA
4,06 US$
BAJO (1Y)
2,33 US$
ALTO (1Y)
8,51 US$
BAJO (24H)
4,05 US$
Alza (24H)
4,24 US$
Volumen (24 h)
33,84 mil US$
80,95 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | 4,06 US$ |